Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
EIF2AK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IFIH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLSCR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100310756 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
IFIT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SP100 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPM1K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMPK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM69 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OAS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSAD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFIT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on